10X Genomics Inc vs Wynn Resorts, Limited — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Wynn Resorts, Limited trades at $95.88 (market cap $9.93B). The key difference: Wynn Resorts, Limited is the larger of the two by market cap, and Wynn Resorts, Limited pays a 1.05% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | WYNN | |
|---|---|---|
Market Cap | $5.48B | $9.93B |
Sector | Health | Consumer Cyclical |
52-Week High | $45.80 | $133.34 |
52-Week Low | $11.34 | $94.78 |
Enterprise Value | $5.02B | $20.29B |
Dividend Yield | — | 1.05% |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →